Drug Abuse & Dependence
Non-clinical drug dependence studies can provide clinical information on drug abuse and dependence, and the obtained non-clinical trial data is conducive to guiding clinical research and rational drug use, warning of abuse tendency, and is of great significance for the research and development of drugs for drug withdrawal, dependence tendency and central nervous system action. JOINN has established a dependency assessment method based on the guidelines of FDA, ICH, EMA and NMPA, and has advanced and complete test equipment, which complies with international GLP standards, and can provide customers with a complete set of abuse and dependency assessment services.
GLP Services:
Autonomous Administration Test
Conditioned Place Preference/Aversion
Behavioral Sensitization Test
Drug Identification Test
Natural Withdrawal Test
Urgent Withdrawal Test
Administration Route:
Except for the autonomous drug administration trial, which is only suitable for intravenous drug administration, other trial items can be suitable for oral, subcutaneous, muscular, intravenous, abdominal, and local drug administration, etc.